← FDA DRUG APPROVALS

FDA ANDA · ANDA071315

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: TEVA

APPLICATION
ANDA071315
TYPE
ANDA
ORIGINAL APPROVAL
1993-06-30
LATEST ACTION
2001-08-30
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/5ML · SOLUTION · ORAL

Approval history

2001-08-30Manufacturing (CMC) · Supplement 1AP
1993-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →